Howard Levy

9.5k total citations · 1 hit paper
119 papers, 5.4k citations indexed

About

Howard Levy is a scholar working on Epidemiology, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Howard Levy has authored 119 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 21 papers in Infectious Diseases and 21 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Howard Levy's work include Sepsis Diagnosis and Treatment (28 papers), Viral Infections and Vectors (11 papers) and Clinical Nutrition and Gastroenterology (9 papers). Howard Levy is often cited by papers focused on Sepsis Diagnosis and Treatment (28 papers), Viral Infections and Vectors (11 papers) and Clinical Nutrition and Gastroenterology (9 papers). Howard Levy collaborates with scholars based in United States, South Africa and Belgium. Howard Levy's co-authors include Pierre‐François Laterre, William L. Macias, Edward Abraham, Richard G. Wunderink, Michel Boivin, Becky Bates, C. J. Peters, Gary L. Simpson, Mark D. Williams and Mark J. Rumbak and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Howard Levy

114 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

2005 567 citations Edward Abraham, Pierre‐François Laterre et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Howard Levy United States	39	2.6k	1.2k	1.0k	939	704	119	5.4k
Bruno François France	43	2.9k 1.1×	1.1k 0.9×	1.9k 1.9×	1.3k 1.3×	1.4k 2.0×	177	7.3k
Jean‐Paul Mira France	40	2.0k 0.8×	785 0.6×	996 1.0×	1.4k 1.5×	766 1.1×	116	5.9k
Juan Gea‐Banacloche United States	30	4.0k 1.6×	1.0k 0.9×	1.4k 1.3×	1.0k 1.1×	1.1k 1.6×	102	7.2k
Frédéric Pène France	46	2.2k 0.9×	716 0.6×	1.1k 1.0×	1.2k 1.3×	751 1.1×	231	6.7k
L. G. Thijs Netherlands	43	1.7k 0.7×	306 0.3×	857 0.8×	1.0k 1.1×	1.2k 1.7×	159	6.2k
L. G. Thijs Netherlands	16	5.2k 2.0×	662 0.5×	2.3k 2.3×	1.8k 2.0×	2.1k 3.0×	20	9.8k
Peter Q. Eichacker United States	36	2.1k 0.8×	396 0.3×	793 0.8×	947 1.0×	498 0.7×	152	5.2k
Stephanie Eaton United States	7	3.0k 1.2×	479 0.4×	1.2k 1.2×	735 0.8×	688 1.0×	7	5.0k
Margaret M. Johnson United States	30	1.0k 0.4×	837 0.7×	729 0.7×	1.4k 1.5×	489 0.7×	113	4.1k
Jan G. Zijlstra Netherlands	40	1.2k 0.5×	446 0.4×	445 0.4×	1.0k 1.1×	782 1.1×	255	6.0k

Countries citing papers authored by Howard Levy

Since Specialization

Citations

This map shows the geographic impact of Howard Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Levy more than expected).

Fields of papers citing papers by Howard Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Levy. The network helps show where Howard Levy may publish in the future.

Co-authorship network of co-authors of Howard Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Levy. A scholar is included among the top collaborators of Howard Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Levy. Howard Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahlangu, Johnny, et al.. (2021). Efficacy and safety of subcutaneous prophylaxis with dalcinonacog alfa in adults with haemophilia B. Haemophilia. 27(4). 574–580. 11 indexed citations

Lyden, Patrick D., Kent E. Pryor, Thomas P. Davis, et al.. (2021). Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation. Frontiers in Neurology. 12. 593582–593582. 12 indexed citations

Belcher, John D., Edward D. Gomperts, Julia Nguyen, et al.. (2018). Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia. PLoS ONE. 13(10). e0205194–e0205194. 43 indexed citations

Gomperts, Edward D., John D. Belcher, Leo E. Otterbein, et al.. (2017). The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso‐occlusive crises. American Journal of Hematology. 92(6). 569–582. 34 indexed citations

Linden, Philippe Van der, David Jahoda, R. Heylen, et al.. (2011). A Double-Blind, Randomized, Multicenter Study of MP4OX for Treatment of Perioperative Hypotension in Patients Undergoing Primary Hip Arthroplasty Under Spinal Anesthesia. Anesthesia & Analgesia. 112(4). 759–773. 13 indexed citations

Goldstein, Brahm, Simon Nadel, Mark Peters, et al.. (2006). ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*. Pediatric Critical Care Medicine. 7(3). 200–211. 38 indexed citations

Laterre, Pierre‐François, Gary Garber, Howard Levy, et al.. (2005). Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*. Critical Care Medicine. 33(5). 952–961. 132 indexed citations

Booth, Frank V. McL., Mary B. Short, Andrew F. Shorr, et al.. (2005). Application of a population-based severity scoring system to individual patients results in frequent misclassification. Critical Care. 9(5). R522–9. 26 indexed citations

Bernard, Gordon R., Benjamin D. Margolis, Harvey M. Shanies, et al.. (2004). Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US). CHEST Journal. 125(6). 2206–2216. 105 indexed citations

10.

Dhainaut, Jean-François, Pierre-François Laterre, Steven P. LaRosa, et al.. (2003). The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*. Critical Care Medicine. 31(9). 2291–2301. 69 indexed citations

11.

Ely, E. Wesley, Pierre‐François Laterre, Derek C. Angus, et al.. (2003). Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Critical Care Medicine. 31(1). 12–19. 192 indexed citations

12.

Schuster, Daniel P., Michael H. Metzler, Steven M. Opal, et al.. (2003). Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial*. Critical Care Medicine. 31(6). 1612–1619. 62 indexed citations

13.

Levy, Howard, et al.. (1997). Pleural Fluid Characteristics in Hantavirus Pulmonary Syndrome. CHEST Journal. 112(4). 1133–1136. 39 indexed citations

14.

Levy, Howard, et al.. (1995). Adsorption of Charged Non-albumin Bound Drugs by Amorphous Silica. Journal of Toxicology Clinical Toxicology. 33(5). 457–462. 3 indexed citations

15.

Levy, Howard & Steven Q. Simpson. (1994). Hantavirus Pulmonary Syndrome. American Journal of Respiratory and Critical Care Medicine. 149(6). 1710–1713. 29 indexed citations

16.

Levy, Howard. (1994). Comparison of Ballard Catheter Bronchoalveolar Lavage With Bronchoscopic Bronchoalveolar Lavage. CHEST Journal. 106(6). 1753–1756. 12 indexed citations

17.

Brown, Ken, et al.. (1993). Overdose of risperidone. Annals of Emergency Medicine. 22(12). 1908–1910. 39 indexed citations

18.

Levy, Howard, et al.. (1993). A Comparative Study of Oral Endotracheal Tube Securing Methods. CHEST Journal. 104(5). 1537–1540. 31 indexed citations

19.

Conlan, A A, et al.. (1986). Pulmonary resection in the prone position for suppurative lung disease in children. Journal of Thoracic and Cardiovascular Surgery. 92(5). 890–893. 12 indexed citations

20.

Levy, Howard. (1984). LOCKHEED PUSHES STOL TECHNOLOGY. 126(3935). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact